Company intelligence / Profile preview

Perrigo

Ownership
Public · PRGO
Employees
~9300
Development stage
Commercial
01

Overview

Perrigo has a large portfolio of commercialized over-the-counter medicines and self-care products across multiple therapeutic areas. The company also produces generic prescription drugs and infant formulas. It does not focus on novel clinical-stage therapeutics but rather on manufacturing and distributing established medicines under private label/store brands[2][4][6].

Therapeutic areas
GastroenterologyPsychiatryMetabolic DisordersImmunologyDermatologyNeurology
Modalities
Small molecules (OTC drugs and generics)topical formulations (creams, ointments)nutritional products (infant formula)
Industry
Contract Manufacturing Organization
02

Drug pipeline

1 asset

Opill

Commercial
Indications
Women's contraception
03

Partnerships

No major pharma R&D partnerships reported—focuses primarily on retail/private label relationships with major retailers/pharmacies worldwide.
04

Financials

Market cap
$2B
Total revenue
$1B
Enterprise value
$4.9B

Beyond the preview

Go deeper on Perrigo.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Perrigo.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call